Former AusCann CEO joins MGC Pharma as non-executive director by Steve Jones June 5, 2023June 5, 2023 Former AusCann chief executive Layton Mills has joined the board of MGC Pharma as a non-executive […]
AusCann remains in holding pattern as proposed acquisition is delayed by Steve Jones May 1, 2023May 1, 2023
Company news: Cann Global; Elixinol; Bod Science; AusCann; IvyMed Clinic; Botanix by Steve Jones and Martin Lane April 5, 2023April 17, 2023
AusCann offloads 52% of CannPal to founder Layton Mills in move to ‘unlock potential’ of animal business by Steve Jones March 13, 2023March 13, 2023
AusCann boss Layton Mills looks for love in season 10 of Married At First Sight by Martin Lane February 13, 2023August 11, 2023
AusCann invests a further A$3.5m in European venture, sells R&D facility by Steve Jones September 12, 2022September 12, 2022
Company news: MGC Pharma/Extrax; Epsilon; Auscann; Roots; TSN; Emyria by cannabiz team December 16, 2021December 16, 2021
Company news: MGC Pharma; Emyria; ECS Botanics; Rua Bioscience; AusCann; Cannasouth; Cronos; Althea by Martin Lane September 2, 2021February 26, 2022
AusCann starts Australian registration of skincare product for dogs by Martin Lane July 20, 2021July 20, 2021
Company news: Cann Global; ANTG/Asterion; ECS Botanics; AusCann; Creso Pharma by Martin Lane July 5, 2021July 8, 2021
